Risk Reduction in Coronary Heart Disease

NCT00679237 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1600

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronary Heart Disease

Interventions

BEHAVIORAL: smoking cessation
DRUG: betablocker, diuretics, ACEI, ARB,
DRUG: statins, ezetimibe
BEHAVIORAL: training
BIOLOGICAL: influenza vaccine
DRUG: metformin, glimepiride, insulin
BEHAVIORAL: weight reduction

Sponsor

Sorlandet Hospital HF

Collaborators

[object Object]